Navigation Links
Iowa State University researcher looks to use nanoparticles for food safety
Date:4/10/2008

Ames, Iowa Byron Brehm-Stecher, assistant professor in food science and human nutrition, has some big ideas for his work with tiny particles. His latest research project will allow him to study the potential of using silver nanoparticles to improve the safety of the worlds food supply.

Although the particles cant be added directly to foods, the ultimate goal of this project is to develop food-related applications such as microbe-resistant fabrics or non-biofouling surfaces. The research, he said, could have a large impact on the safety of foods.

Through our work, we hope to gain a greater understanding of how these materials affect microbial structure or function, Brehm-Stecher said. This may lead to new approaches for killing foodborne pathogens and enhancing food safety. For example, silver nanoparticles are already being used in food packaging to soak up the plant-ripening hormone ethylene, extending the shelf life of fruits. The science is at a basic point right now, but we expect that it will translate into something more applied in the future. Im looking forward to extending this as far as the questions we have will take us.

Brehm-Stecher said they hope to learn more about how silver nanoparticles exert their antimicrobial activities by testing QSI-Nano Silver for its ability to interact with microbial cells.

QSI-Nano Silver is prepared from pure metallic silver that is vaporized in the presence of an inert gas, and then condensed under controlled conditions to form discrete particles smaller than 100 nanometers in diameter. A nanometer is a billionth of a meter. You can get an idea of the size difference between a nanometer and a meter by imagining something the size of a marble sitting next to an object the size of the Earth.

One of the things we do in my lab is to develop multi-ingredient antimicrobial mixtures. I was interested in finding antimicrobials that would be physically compatible with other compounds that were working with, Brehm-Stecher said. It looked like the nanoparticles could provide us with a good solution. I approached QuantumSphere and they were open to sending us compounds and working with us. Were interested in many of the same things. Its a good relationship.

Brehm-Stecher started work on the project in January 2008. He and graduate assistant Heidi Weinkauf have had good results so far.

Its been very fulfilling and exciting to be able to design experiments with Heidi and see what happens, Brehm-Stecher said. The results so far have met and surpassed our expectations, and were only a couple of months into the grant. Every experiment, whether it turns out as expected or not, points us in a new direction and we are now getting some fascinating clues about how nanosilver works as an antimicrobial.

Scientists face many challenges when working with unfamiliar materials. Because Brehm-Stecher and Weinkauf were new to nanoparticle research, they collaborated with QuantumSphere chief scientist Doug Carpenter early on to optimize their test methods and begin generating data.


'/>"/>

Contact: Byron Brehm-Stecher
byron@iastate.edu
515-294-6469
Iowa State University
Source:Eurekalert

Related medicine news :

1. Open Letter to Presidential Candidates on State Health Care Reform
2. Massachusetts Affiliate of Susan G. Komen for the Cure(R) to Challenge States Leaders to Strengthen Breast Cancer Services
3. CamelBak(R) CEO Statement on BPA and Plastic Re-Usable Water Bottles
4. Statement by the American Egg Board and Egg Nutrition Center on AJCN Study on Egg Consumption
5. Paro, the Baby Seal Service Robot From Japan, Finds a New Home in the United States With Help From JETRO
6. Three New States Join Efforts to Screen Newborns for Cystic Fibrosis
7. Scientists Block Prostate Cancer Cells Spread
8. Blocking the effect of inflammation-causing cells lowered prostate cancer cells invasion
9. Statement of SEIU Spokesperson Andrew McDonald Responding to Announcement of Lawsuit by SEIU UHW-W
10. Lierac Paris Expands in the United States at Healthy Skincare Centers at CVS/pharmacy
11. Microwave treatments for enlarged prostate cause blood pressure surges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... attempts to compare student test score performance for the 2015-16 school year across ... state’s voucher programs. Though it highlights important patterns in student test score performance, ...
(Date:4/25/2017)... Las Vegas, NV (PRWEB) , ... April 25, ... ... teeth can now choose a modern procedure that achieves results in a fraction ... orthodontist in Las Vegas, NV, with Significance Dental Specialists, now offers this ...
(Date:4/25/2017)... ... , ... Back Pain Centers of America (BPC), which connects people ... their area, announces the launch of a new and proprietary customer relationship management (CRM) ... reputable physicians to help them with back or neck pain and helps to match ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... analytics to its patient care management module. Using this new feature, sleep physicians ... has been initiated on continuous positive airway pressure (CPAP), oral, or other forms ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
Breaking Medicine Technology: